A double-blind, randomized trial, including frequent patient–physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study

Anja Schweizer, Mohamed Hassanein, Khalifa Abdallah
  • Vascular Health and Risk Management, May 2014, Taylor & Francis
  • DOI: 10.2147/vhrm.s64038

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Mohamed M Hassanein